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Aim To perform SWOT (strengths, weaknesses, opportu-
nities, and threats) analysis of a clinical laboratory as an 
economic model that may be used to improve business 
performance  of  laboratories  by  removing  weaknesses, 
minimizing threats, and using external opportunities and 
internal strengths.
Methods Impact of possible threats to and weaknesses 
of the Clinical Laboratory at Našice General County Hos-
pital business performance and use of strengths and op-
portunities  to  improve  operating  profit  were  simulated 
using models created on the basis of SWOT analysis re-
sults. The operating profit as a measure of profitability of 
the clinical laboratory was defined as total revenue minus 
total expenses and presented using a profit and loss ac-
count. Changes in the input parameters in the profit and 
loss account for 2008 were determined using opportuni-
ties and potential threats, and economic sensitivity analy-
sis was made by using changes in the key parameters. The 
profit and loss account and economic sensitivity analysis 
were tools for quantifying the impact of changes in the 
revenues and expenses on the business operations of clin-
ical laboratory.
Results Results of simulation models showed that opera-
tional profit of €470 723 in 2008 could be reduced to only 
€21 542 if all possible threats became a reality and current 
weaknesses  remained  the  same.  Also,  operational  gain 
could be increased to €535 804 if laboratory strengths and 
opportunities were utilized. If both the opportunities and 
threats became a reality, the operational profit would de-
crease by €384 465.
Conclusion The operational profit of the clinical laborato-
ry could be significantly reduced if all threats became a re-
ality and the current weaknesses remained the same. The 
operational profit could be increased by utilizing strengths 
and opportunities as much as possible. This type of mod-
eling may be used to monitor business operations of any 
clinical laboratory and improve its financial situation by im-
plementing changes in the next fiscal period.
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Increasing health care expenses and implementation of ra-
tionalization have brought about the need for a detailed 
computer modeling of economic business operations on 
which is based the analysis of health care management (1) 
and monitoring of spending, timing, and sources of largest 
or new expenses, and possible savings without changing 
the quality of the work performed (2).
Although a hospital-based clinical laboratory is an integral 
part of a health care system, it may be observed as a sepa-
rate unit. Quality management and good work organiza-
tion aimed at achieving a continuous improvement in pre-
analytical, analytical, and post-analytical phases are part of 
a good laboratory practice (3-5). Successful quality man-
agement in a clinical laboratory setting reduces both the 
need to repeat tests and raw material consumption, lead-
ing to increased business effectiveness.
Analysis of business expenses of a clinical laboratory and 
calculation of the cost of laboratory tests under different 
work conditions are part of the laboratory manager’s job 
(6).  For  an  overall  picture  of  business  performance,  the 
manager has to have a detailed knowledge about reve-
nues and expenses (7), which are used in the assessment 
of the financial profitability of the laboratory in general and 
individual laboratory tests in particular (8).
Increased  productivity  of  clinical  laboratories  is  directly 
associated with the technological development of labo-
ratory diagnosis (9) through automation, infomatization, 
computer networking, consolidation, and integration. Au-
tomation is a process in which laboratory analyzers carry 
out a large number of tests with a minimal participation 
of laboratory staff (10). Consolidation is a merger of labora-
tory and different specialties into new, separate units (eg, 
cytology, pathology, clinical chemistry, transfusiology, nu-
clear medicine, or microbiology). Integration is association 
of laboratories at different levels of health care system into 
an integrated laboratory.
Implementation of laboratory information system may im-
prove work organization, time saving, and control of the 
work process (11,12). In the beginning, a new technology 
incurs expenses because it requires financial investment 
to be made. Financial effectiveness of investments may be 
predicted by using an economic model, ie, a model of lab-
oratory as an economic unit, and by calculating expected 
expenses and revenues resulting from the changes in the 
work of laboratory, which allows making of justifiable 
decisions based on the measured parameters.
To  develop  the  laboratory  model  as  an  economic  unit, 
revenues and expenses have to be compared over a de-
fined period of time, usually, over one year. The difference 
between total revenues and total expenses clearly shows 
whether or not the laboratory is profitable and presents a 
starting point for choosing the right measures to improve 
laboratory business operations.
The aim of the study was to analyze business operations 
of a clinical laboratory as an economic unit. For that pur-
pose, we used a SWOT analysis, ie, the analysis of strengths, 
weaknesses,  opportunities,  and  threats,  to  identify  the 
possibilities of improving laboratory business operations. 
Based on the SWOT analysis, it is necessary to identify and 
present possible calculated models of economic opera-
tions for the clinical laboratory. An economic sensitivity 
analysis of these business models revealed the factors in-
fluencing the profitability of clinical laboratory’s business 
operations.  We  hypothesized  that  comparison  of  these 
models enables decision-making for the economic benefit 
of a clinical laboratory.
Material and MetHods
sWot analysis
Business conditions and possibilities to improve business 
operations of a clinical laboratory were investigated by us-
ing the SWOT analysis, which reveals strengths, weakness-
es, opportunities, and threats that can have an effect on an 
organization unit (in the order as presented in Table 1), ie, 
clinical laboratory (13,14). Strengths and weaknesses refer 
to internal characteristics of a clinical laboratory, whereas 
opportunities and threats are external factors. Strengths 
describe advantages of the laboratory in comparison with 
other similar laboratories in the same geographical region 
of 50 km in diameter, covering a population of approxi-
mately a million. Opportunities refer to conditions in the 
laboratory that may lead to the improvement in business 
operations. Weaknesses refer to shortcomings in the work 
of laboratory and removing the weaknesses would create 
new opportunities that could improve the quality of work 
and, consequently, increase profitability. Threats represent 
conditions that may lead to difficulties in business opera-
tions (15).
The SWOT analysis reveals possibilities for optimization of 
laboratory  work  if  work-related  weaknesses  and  external 
threats are reduced or completely removed, strengths of the 
laboratory increased, and most or all opportunities utilized.515 Buljanović et al: Clinical laboratory as an economic model for business performance analysis
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Data for the SWOT analysis were collected from (a) publica-
tions (by type and number) affiliated to the laboratory over 
a single calendar year; (b) expenses of laboratory material 
(data obtained from the hospital pharmacy); (c) gross sala-
ries for laboratory staff (data obtained from the adminis-
trative office); and (d) overhead and common hospital ex-
penses (eg, education of residents, building maintenance, 
etc.), which make 7% of the total hospital expenses (per-
centage of the expenses equals the percentage of hospital 
employees working in the laboratory) and are covered by 
the laboratory.
Opportunities were analyzed (additional tests performed 
in the laboratory) by listing all the tests performed within 
a systematic physical examination, tests required for physi-
cian’s certificate, and tests that are directly paid and provid-
ed by other clinical laboratories in the region in the same 
time period.
Profit and loss account
We analyzed business operations of the laboratory in one-
year period, using a profit and loss account to express the 
laboratory’s profitability. The basic elements in the profit 
and loss account included revenues, expenses, and their 
difference, which expressed final profit or loss and showed 
the  laboratory’s  profitability.  Revenues  come  from  fees 
charged for the tests performed, and expenses refer to all 
expenses needed to earn revenues.
To use this method for analysis of laboratory’s business 
performance, for the purpose of profit and loss account, 
revenues and expenses were additionally divided into dif-
ferent  categories.  Revenues  were  divided  according  to 
the patient’s referral (hospital, outpatient services, primary 
care) and other sources, such as financial donations or di-
rect financial remuneration for provided laboratory servic-
es (profit and loss account, Table 2). Expenses were divided 
into direct material expenses, other production expenses 
(direct labor and overhead expenses), and general expens-
es (indirect and others).
A profit and loss account provides a profit breakdown ex-
pressed through a contribution margin, gross profit, and 
operating profit. A contribution margin is the total revenue 
(charged laboratory tests and other income) minus direct 
material expenses. Gross profit is the difference between 
the total revenue and total production expenses (direct 
material expenses and other production expenses). Oper-
ating profit with a positive number sign indicates profit-
able business operations, whereas negative number sign 
indicates unprofitable business operations.
economic sensitivity analysis
Economic  sensitivity  analysis  was  used  to  show  how 
business operations may be changed by changing one 
or more parameters in the profit and loss account (16). 
This type of analysis showed the influence of changes 
in the revenues or expenses on business operations, ie, 
profitability of the clinical laboratory expressed as oper-
ating profit. By changing input parameters, revenues or 
expenses, we created six models for changing operat-
ing profit in comparison with the basic model of clinical 
laboratory business operations. In other words, econom-
ic sensitivity analysis was based on the data obtained by 
SWOT analysis.
Data for the following models are shown (Table 2): auto-
mation, informatization, three employees less, additional 
tests, reduced tests for outpatients, and reduced test for 
primary health care.
Data on income in Croatian Kuna (HRK) were converted at 
the exchange rate of €1 to HRK 7.26 (June 2010 exchange 
rate list).
taBle 1. sWot analysis of the Clinical laboratory at našice General County Hospital
strenGHts WeaKnesses
Available to patients 24 h a day No information system
Wide range of different laboratory tests Incomplete automation
Profitable performance High direct labor expenses (gross salaries)
No system of measuring labor efficiency
oPPortUnities tHreats
Automation Reduced tests for outpatient services
Informatization Reduced tests for primary health care
Reduction in direct labor expenses New laboratory opening
Additional services currently provided by other laboratories in the regionCLINICAL SCIENCES 516 Croat Med J. 2011; 52: 513-9
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institution
The Clinical Laboratory at Našice General County Hospital 
was chosen as a case laboratory for this study. The SWOT 
analysis and profit and loss account were performed for 
the fiscal year of 2008, which corresponds to a calendar 
year. The Clinical Laboratory is a typical provider of clinical 
laboratory services for all hospital in-patients, hospital out-
patients, and patients referred from primary care offices in 
the region. The Našice General County Hospital is a non-
profitable health institution supported by the state budget 
through the Croatian Institute of Health Insurance.
resUlts
sWot analysis
Table 1 shows the SWOT analysis results. Strengths include 
availability to patients 24 hours a day, which is a unique 
service offered by no other laboratories receiving patients 
referred from primary practice in the region; wide range of 
different tests; and profitable business operations in 2008 
(Table 2). Weaknesses consist of the lack of information 
system, incomplete automation, high costs of direct labor, 
and a lack of system for measuring labor efficiency of the 
laboratory staff.
Opportunities include automation, informatization, reduc-
tion in direct labor expenses along with the implementa-
tion of automation and informatization, and increase in 
additional tests that are currently performed by other lab-
oratories in the region. Threats include possible cessation 
of tests for outpatient services and patients referred from 
primary care.
Clinical laboratory model
The basic model of clinical laboratory as an economic unit 
shows the actual business operations in 2008 (Table 2, real 
system). In 2008 fiscal year, the clinical laboratory oper-
ated profitably and realized a positive operating profit of 
€470 423 (Table 2).
economic modeling of a clinical laboratory
Economic sensitivity analysis was used to develop six cal-
culated models to change the operating profit with regard 
to the basic model. The models include automation mod-
el, informatization model, “three employees less” model, 
additional tests model, reduced laboratory tests for outpa-
tient services model, and reduced laboratory tests for pri-
mary care model.
taBle 2. the profit and loss account for the Clinical laboratory at našice General County Hospital in 2008 and models created by economic sensitiv-
ity analysis (in €)
Models







reduced tests for 
outpatient services
reduced tests for 
primary health care
(1) revenue
(1.1) hospital 534 241 534 241 534 241    534 241    534 241 534 241 534 241
(1.2) outpatient services 311 049 311 049 311 049    311 049    311 049   91 991 311 049
(1.3) primary health care 340 740 340 740 340 740    340 740    340 740 340 740      0
(1.4) other 10 899 10 899 10 899      10 899      75 342   10 899   10 899
total revenue 1 196 929 1 196 929 1 196 929 1 196 929 1 261 372 977 871 856 189
(2) expenses
(2.1) directs materials expenses 211 895 231 983 211 895    231 983   228 879 173 721 139 152
(2.2) other production expenses 366 699 366 699 366 699    310 783   366 699 366 699 366 699
(2.2.1) direct labor 352 128 352 128 352 128    296 212    352 128 352 128 352,128
(2.2.2) production overhead expenses 14 571 14 571 14 571      14 571      14 571   14 571    14 571
(2.3) general expenses 147 912 147 912 166 783    166 783     147 912 147 912 147 912
(2.3.1) indirect 125 925 125 925 126 889    126 889    125 925 125 925 125 925
(2.3.2) other 21 987 21 987 39 894     39 894      21 987   21 987    21 987
total expenses 726 506 746 594 745 377   709 549    743 490 688 332 653 763
(3) Contribution margin (1 – 2.1) 985 034 964 946 985 034   964 946 1 032 493 804 150 717 037
(4) Gross profit (3 – 2.2) 618 335 598 247 618 335    654 163   665 794 437 451 350 338
(5) operating profit (4 – 2.3) 470 423 450 335 451 552    487 380    517 882 289 539 202 426517 Buljanović et al: Clinical laboratory as an economic model for business performance analysis
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The automation model (Table 2) showed that the operat-
ing profit decreased to €450 335 in comparison with op-
erating profit produced by the basic model, but increased 
the expenses related to laboratory reagents (direct mate-
rial expenses) by €20 088 to cover for the cost of laboratory 
automation. The informatization model (Table 2) increased 
other expenses by €18 871, which led to a decreased oper-
ating profit of €451 552 in comparison with that produced 
by the basic model.
By simultaneous informatization and automation, it is pos-
sible to reduce direct labor expenses by reducing the num-
ber of staff (gross salaries) by three, as shown by the “three 
employees less” model (Table 2). According to this model, 
operating profit was €487 380 (three gross salaries amount 
to €55 916), ie, it increased by €16 957 in comparison with 
the operating profit of the basic model.
The additional tests model (Table 2) assumed increased 
number of tests performed as part of systematic physical 
examination, for the purpose of physician’s certificate, and 
upon personal request by the patient (direct payment), 
which is a service currently offered by other laboratories 
in the region. According to this model, the operating profit 
would increase by €47 459 and amount to €517,882. Oth-
er revenue would increase by €64 443 (€75 342-10 899, Ta-
ble 2) and expenses would increase by €16 984 (€228 879-
211 895, Table 2), equaling the cost of laboratory reagents 
used for additional tests.
The reduced laboratory test for outpatient services mod-
el (Table 2) reduced the number of specialized laboratory 
tests and consequently the revenue in this category. Ac-
cording to this model, the operating profit was reduced by 
€180 884, totaling €289 539. In the model of reduced labo-
ratory testing for primary care (Table 2), there were no tests 
performed  for  primary  care  patients  and,  consequently, 
there was no revenue in this category. The total revenue 
was, therefore, reduced by the revenue in this category 
and led to a decrease in the operating profit of €267 997 in 
comparison with that produced by the basic model, total-
ing €202 426.
disCUssion
In this study, the SWOT analysis showed strengths, weak-
nesses, opportunities, and threats for the Clinical Labo-
ratory at Našice General County Hospital. The important 
strength of the laboratory was its 24-hour availability ev-
ery day of the year, because the laboratory works around 
the clock in three shifts. None of the laboratories receiv-
ing patients referred from primary care and located within 
50 km from the Našice General County Hospital are con-
stantly available, but operate in two shifts on work days 
only. The next strength was the wider range of tests of-
fered in comparison with the range of tests performed 
by other laboratories for the primary care, followed by the 
profitable business operations. The profitable business op-
erations were shown by the profit and loss account, where 
operating profit in 2008 was €470 423. The strengths of the 
laboratory should be further developed by including new 
tests whose profitability should be evaluated beforehand, 
as required by good financial management (17). New tests 
should be introduced according to the market demands, 
which  should  be  investigated  through  interviews  with 
physicians in the geographic region and health insurance 
companies.
The weaknesses of the laboratory include lack of informa-
tization and incomplete automation, high expenses of di-
rect labor, ie, gross salaries, which account for 4% of total 
expenses, and lack of the system for measuring labor ef-
ficiency. It is not possible to financially stimulate the labo-
ratory staff to work more efficiently, because the labora-
tory is an organizational unit within the hospital financed 
from the state budget and each employee receives a sal-
ary determined by the number of points for their pro-
fessional qualification level and conditions of work. This 
salary system is used statewide in Croatia and cannot be 
changed by the laboratory manager. This weakness may 
be reduced by finding other possible ways to motivate 
the staff and value their work in a non-financial way, for 
example,  by  internal  reorganization  of  the  laboratory 
where one employee would be entrusted with manag-
ing 2-3 other laboratory employees and thus earn respect 
and feel more satisfied. In the following year, automation 
and informatization could be implemented. Irrespective 
of the cost, the benefits of informatization and automa-
tion are unquestionable as they substantially increase the 
quality of services (18). Consequently, according to our 
estimate, informatization and automation would reduce 
by three the number of employees required to perform 
the same number of laboratory tests as in the analyzed 
year, which would then reduce the direct labor expens-
es, ie, gross salaries expense. Reduction in direct labor ex-
penses would be permanent. The cost of possible auto-
mation of €20 088 would be covered by increased price 
of laboratory reagents over a specified period of time, 
usually a five-year period. After the automation was 
paid off, the price of reagents would be reduced CLINICAL SCIENCES 518 Croat Med J. 2011; 52: 513-9
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back  to  original  one.  Informatization  that  would  cost 
€18 871 could be fully paid off at once.
It should be noted that the investment in informatization 
is treated as a one-time expense, meaning that the infor-
matization purchase value is expressed as an expense in 
the year when the purchase was made. This rule applies to 
all institutions financed by the government budget. If the 
laboratory was privately owned, the purchase value of the 
informatization equipment of €18 871 would be divided 
over four years, increasing the annual expenses over the 
four-year period by €4 717.75. By automation, informatiza-
tion, and reduced number of employees, the weakness of 
having high labor expenses would be transformed into an 
opportunity to increase laboratory test volume and reduce 
labor expenses. In this way, interdependence of calculated 
models is demonstrated because the expenses of automa-
tion (€20 088) and informatization (€18 871) are lost by re-
ducing the expenses of the gross salaries of the three em-
ployees (€55 916).
New opportunity for every clinical laboratory would be 
to take on additional laboratory tests. Studies into market 
expansion show that profitability is increased with an in-
crease in the number of users, which is the usual practice 
in the United States and other market-oriented countries 
(19). Additional work for the Clinical Laboratory at Našice 
General County Hospital would include laboratory tests 
that are currently not performed at the clinical laboratory 
but are performed at other laboratories in the close region 
and include tests for the purpose of issuing physician’s cer-
tificates, tests performed within systematic physical exami-
nations, and tests paid directly by the patients. By perform-
ing additional tests, the operating profit would increase by 
€47 459. If possibilities and opportunities were realized, the 
operating profit would increase to €535 804, which unifies 
simultaneous application of the first four models: automa-
tion, informatization, three employees less, and additional 
tests. Together they would represent the best model to im-
prove business operations.
The threat to the clinical laboratory is the establishment 
of a new clinical laboratory that would take over part of 
the patients and thus lead to the reduction in the num-
ber of tests performed, as shown by the models of eco-
nomic operations: models of reduced tests for outpatient 
services and reduced tests for primary care. If this threat 
became a reality, the operating profit would be reduced 
to €202 426 (€267 997 less). Patients can request spe-
cialized tests in other laboratories if they are willing 
to pay travel expenses to a remote laboratory. Reduced 
tests for outpatient services would lead to a reduction in 
the operating profit by €180 884, ie, the operating profit 
would amount to €289 539. If a new laboratory was estab-
lished, it would substantially reduce the operating profit of 
the clinical laboratory, because the laboratory could take 
over patients referred from the primary care and perform 
specialist tests for outpatient services. In that case, the op-
erating profit would be reduced by €448 881 and amount 
to only €21 541, which combines both models of reducing 
the tests. If the threat of reduction in the number of tests 
performed was removed, continuous development and 
market surveillance are needed. Reducing expenses in all 
categories, which are greater in the developed European 
countries than in the United States (19), by carefully moni-
toring the labor process may lead to improved business 
performance of the clinical laboratory irrespective of the 
way in which it is financed. There is a possibility to realize 
various combinations of mentioned models, and their in-
dividual presentation enables computer modeling of eco-
nomic operations.
According to the SWOT, profit and loss account, and eco-
nomic sensitivity analyses, it is possible to quantify the ef-
fects of each described change. If all threats became a re-
ality, their sum would amount to €448 881, and the sum 
of  total  opportunities  only  to  €65.381.  Therefore,  total 
risk resulting from the threats is seven times greater than 
the possible growth based on the opportunities. In other 
words, the results showed that there is a possibility to re-
duce the operating profit from €470 723 to only €21 542, 
which is a 95% decrease, and the possibility to increase 
the operating profit to €535 804, which is a 14% increase. A 
new laboratory seems to be the greatest threat.
The financial situation in the health care system in the Re-
public of Croatia is unfavorable, but this type of analysis could 
lead to a positive financial shift despite the fact that making 
profit is not the primary function of the health system. Every 
health department manager should have basic knowledge 
of economic principles and their application. By using the 
knowledge of economy and analysis presented in this arti-
cle, the Clinical Laboratory of Našice General County Hospi-
tal may increase its profitability and become a role model for 
other laboratories in business performance analysis.
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